Kathryn M. Schak, MD

  • 3Articles
  • 27.8KReads
  • 2019–2023Active
  • 22Collaborators
  • 160Citations

About

Kathryn M. Schak, MD, is affiliated with the Department of Psychiatry and Psychology at the Mayo Clinic Depression Center and Mayo Clinic College of Medicine in Rochester, Minnesota. Her publications from 2019 to 2023 focus on treatment-resistant depression, including studies on intravenous ketamine and intranasal esketamine, as well as factors influencing remission rates such as body mass index. She has also contributed research on the effects of maternal perinatal opioid use on neonatal outcomes.

Publications

JCP
Ketamine vs Esketamine for TRD
PCC
JCP

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.